Quoin Pharmaceuticals, Ltd.
QNRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $5,429 | $4,597 | $121 |
| - Cash | $1,831 | $1,668 | $3,822 | $3,623 |
| + Debt | $0 | $0 | $2,774 | $2,924 |
| Enterprise Value | – | $3,760 | $3,548 | -$578 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3,923 | -$3,768 | -$3,932 | -$2,380 |
| % Margin | – | – | – | – |
| Net Income | -$3,948 | -$3,696 | -$3,812 | -$2,311 |
| % Margin | – | – | – | – |
| EPS Diluted | -6.71 | -6.28 | -6.5 | -12.41 |
| % Growth | -6.8% | 3.4% | 47.6% | – |
| Operating Cash Flow | -$2,225 | -$3,686 | -$2,594 | -$2,237 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2,225 | -$3,686 | -$2,594 | -$2,237 |